Back to top

medical: Archive

Zacks Equity Research

ITGR Shares Down Despite Q3 Earnings & Revenues Beat Estimates

Integer Holdings posts strong Q3 results with earnings and revenue beat, but shares plunge on a softer 2026 growth outlook.

PODDNegative Net Change PAHCPositive Net Change VCYTPositive Net Change ITGRNegative Net Change

Zacks Equity Research

Reasons to Hold Fresenius Medical Stock in Your Portfolio for Now

FMS acquisitions, partnerships and global reach fuel growth, though rising costs weigh on near-term prospects.

MASINegative Net Change FMSPositive Net Change MMSINegative Net Change WSTNegative Net Change

Zacks Equity Research

HCA Q3 Earnings Beat Estimates on Rising Inpatient Surgery Cases

HCA Healthcare's Q3 earnings rise 42% y/y on stronger patient volumes and rising inpatient surgeries, prompting management to lift its 2025 outlook.

UHSPositive Net Change HCAPositive Net Change ANIPNegative Net Change EHCNegative Net Change

Zacks Equity Research

Community Health Q3 Earnings Beat on Rising Same-Store Admissions

CYH's Q3 earnings surge on higher same-store admissions, cost cuts and a stronger payor mix, swinging to a $171M profit from a loss last year.

UHSPositive Net Change CYHPositive Net Change ANIPNegative Net Change EHCNegative Net Change

Sundeep Ganoria

NVO vs. GPCR: Which Obesity Stock is the Better Buy Right Now?

Novo Nordisk faces headwinds and leadership shifts, while Structure Therapeutics eyes pivotal obesity-drug data later this year.

NVONegative Net Change LLYPositive Net Change GPCRNegative Net Change

Zacks Equity Research

The Zacks Analyst Blog Highlights Amazon.com, Wells Fargo, Amgen, IDT and Village Super Market

Zacks spotlights Amazon, Wells Fargo, Amgen, IDT and Village Super Market in its latest Analyst Blog, showcasing diverse growth drivers and risks.

AMZNPositive Net Change WFCPositive Net Change AMGNNegative Net Change IDTPositive Net Change VLGEANegative Net Change

Aparajita Dutta

Trade Truce Hope: How US-China Talks Could Boost Healthcare ETFs

Hopes of a U.S.-China trade truce are lifting sentiment for healthcare ETFs like XLV, IYH, and VHT, which could gain from easing tariffs and lower costs.

JNJNegative Net Change LLYPositive Net Change XLVPositive Net Change IYHPositive Net Change VHTPositive Net Change GEHCPositive Net Change

Ekta Bagri

PFE versus BMY: Which Large Oncology Drugmaker Is a Better Pick Now?

Bristol Myers edges past Pfizer as the stronger oncology pick, backed by new drug launches, acquisitions and pipeline strength

BMYNo Net Change PFEPositive Net Change

Zacks Equity Research

Best Momentum Stocks to Buy for Oct. 24

ASM, IGC and RY made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on Oct. 24, 2025.

RYPositive Net Change IGCPositive Net Change ASMNegative Net Change

Zacks Equity Research

Incyte Gears Up to Report Q3 Earnings: Is a Beat in the Cards?

INCY eyes strong Q3 performance with Jakafi, Opzelura, and new launches like Niktimvo driving revenues.

NVSNegative Net Change LLYPositive Net Change INCYPositive Net Change EXASNegative Net Change

Zacks Equity Research

REGN Q3 Earnings: Will Higher Dupixent Profits Offset Eylea Sales Decline?

Regeneron's Q3 earnings on Oct. 28 will likely spotlight Dupixent profits and strong Eylea HD uptake amid lingering Eylea competition.

REGNPositive Net Change ALNYNegative Net Change NVSNegative Net Change INCYPositive Net Change

Kaibalya Pravo Dey

UnitedHealth Recovers Its Rhythm Before Q3 Earnings: Time to Buy?

UNH's Q3 results hinge on premium growth and Optum gains amid rising costs and margin pressure.

UNHPositive Net Change HUMNegative Net Change MOHPositive Net Change

Sundeep Ganoria

Here's How Eli Lilly's Oncology Drugs Are Poised Ahead of Q3 Earnings

LLY's oncology portfolio, led by Verzenio, is set for double-digit growth as investors eye Q3 results beyond its obesity drugs.

AZNNegative Net Change PFEPositive Net Change MRKPositive Net Change LLYPositive Net Change

Zacks Equity Research

Will SYK's Q3 Results Reflect MedSurg Strength & Rebound in Orthopaedics?

Stryker's Q3 results are expected to highlight MedSurg strength and solid robotics-led growth in Orthopaedics, partly offset by tariff headwinds.

SYKNegative Net Change MCKPositive Net Change EWNegative Net Change GMEDNegative Net Change

Zacks Equity Research

Pharma, Specialty Units Likely to Drive Cardinal Health's Q1 Earnings

CAH's Pharmaceutical and Specialty units are expected to have fueled double-digit revenue growth in Q1 FY26 despite tariff and cost headwinds.

BDXNegative Net Change CAHPositive Net Change MCKPositive Net Change CORPositive Net Change

Zacks Equity Research

Here's How Charles River Stock Is Placed Ahead of Q3 Earnings

CRL heads into Q3 earnings with steady RMS growth but faces DSA headwinds from tight biotech budgets.

CRLPositive Net Change ANIPNegative Net Change EXASNegative Net Change EHCNegative Net Change

Swayta Shah

5 Stocks With Robust Sales Growth to Buy Amid a Challenging Backdrop

Amid market volatility, strong sales growth makes stocks like Lamb Weston, UHS, FirstEnergy, NetEase and JPMorgan compelling buys.

JPMPositive Net Change FEPositive Net Change UHSPositive Net Change NTESNegative Net Change LWPositive Net Change

Mark Vickery

Top Research Reports for Amazon.com, Wells Fargo & Amgen

Amazon's AI push, Wells Fargo's post-cap growth, and Amgen's new drug momentum headline Zacks' latest top analyst reports.

AMZNPositive Net Change WFCPositive Net Change AMXNegative Net Change AMGNNegative Net Change MMCNegative Net Change IDTPositive Net Change VLGEANegative Net Change RTXNegative Net Change

Shaun Pruitt

Buy the Post-Earnings Surge in Intuitive Surgical (ISRG) Stock?

Intuitive Surgical's stock has been on a tear since the medical pioneer exceeded Q3 expectations on Tuesday and provided positive guidance that left investors hyped about rising demand for robotic-assisted surgical systems.

ISRGNegative Net Change

Zacks Equity Research

Viking Therapeutics Posts Wider-Than-Expected Loss in Q3, Sales Nil

VKTX posts a wider Q3 loss and no sales, as R&D costs surge and obesity drug studies drive spending higher.

ALNYNegative Net Change ALKSNegative Net Change VKTXPositive Net Change HOWLPositive Net Change

Zacks Equity Research

Here's Why You Should Add OPKO Health Stock to Your Portfolio

OPK benefits from RAYALDEE momentum, strategic deals and advancing trials amid stiff competition and dependence risks.

MASINegative Net Change MMSINegative Net Change WSTNegative Net Change OPKNegative Net Change

Zacks Equity Research

Can Sustained Strength in Water Drive ECL Stock Before Q3 Earnings?

Ecolab's Water and Pest units show strength ahead of third-quarter 2025, but softness in Paper and macroeconomic headwinds may weigh on growth.

ECLPositive Net Change ESIPositive Net Change COIHYPositive Net Change SYIEYPositive Net Change

Zacks Equity Research

Molina Healthcare Q3 Earnings Miss Estimates on Rising Expenses

MOH's Q3 earnings plunge 69% as rising medical and administrative costs offset higher premiums and revenue gains.

MOHPositive Net Change EVRPositive Net Change ANIPNegative Net Change EXASNegative Net Change

Zacks Equity Research

WST Stock Up on Q3 Earnings Beat, EPS View Raised on Demand & FX Benefit

West Pharmaceutical's strong Q3 beat and raised EPS outlook highlight robust demand, FX tailwinds, and solid growth in Proprietary Products.

BSXNegative Net Change MASINegative Net Change MMSINegative Net Change WSTNegative Net Change

Zacks Equity Research

Will Lower Patient Days Affect Tenet Healthcare's Q3 Earnings?

THC's third-quarter results may show profit growth despite lower patient days and mixed hospital trends.

THCPositive Net Change SEMPositive Net Change NVSTPositive Net Change ERASPositive Net Change